公司资料
JanOne 股价、新闻与催化剂
- 股票代码:
- JAN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
31.20 USD (+1.60%)
收盘价
最后更新: 2026年8月24日
4.76B USD
市值
股价为何变动
As of Aug 24, 2026, JAN closed up 1.60% at $31.20. No new same-company headline was identified in the current news window.
公司概览
业务概览
JanOne was a biotechnology or life-sciences company that went through multiple strategic transformations and rebrandings over time. Its story is best understood as a historical small-cap name rather than a stable therapeutic franchise.
所在地与行业分类
JanOne was headquartered in the United States and listed on NASDAQ. It sat in small-cap biotech and life sciences.
商业模式特征
The company depended on corporate strategy, capital allocation, and the ability to find a sustainable business identity. Investors historically watched restructurings and repositioning efforts.
生物医药行业定位
JanOne belongs to the historical repositioning bucket within the biotech universe. It is a legacy ticker where strategy mattered as much as science.
未来催化剂
- JanOne is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live development milestone. The market is focused on what remains.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。